The possibility of harmonizing the recombinant erythropoietin specific activity determination method with European Pharmacopoeia

by A. K. Yakovlev, L. A. Gayderova, V. N. Podkuiko, R. A. Volkova, N. A. Alpatova, Yu. V. Olefir
Published 2017-05-01

Assessment of biotechnological products specific activity

by N. A. Alpatova, L. A. Gayderova, A. K. Yakovlev, E. V. Motuzova, S. L. Lysikova, A. A. Soldatov, Zh. I. Avdeeva
Published 2018-02-01

The stages in standardizing erythropoietin preparations

by A. K. Yakovlev, L. A. Gayderova, N. A. Alpatova, T. N. Lobanova, T. A. Batuashvili, L. V. Simutenko, E. L. Postnova, E. I. Yurchikova
Published 2018-02-01

Studying of the standardization principles of pharmacological activity of recombinant erythropoietin preparations

by A. K. Yakovlev, L. A. Gayderova, N. A. Alpatova, T. N. Lobanova, E. L. Postnova, E. I. Yurchikova, T. A. Batuashvili, R. A. Volkova, V. N. Podkuiko, Yu. V. Olefir
Published 2017-05-01

Methodological approaches to preclinical evaluation of immunobiological serum products and their side effects

by V. N. Podkuyko, A. K. Yakovlev, V. P. Krasnyansky, S. V. Borisevich, N. K. Chernikova, E. A. Yakovlev, A. P. Pirozhkov, D. N. Lega, S. V. Nazarov, E. V. Gordeev, Ya. V. Polyansky, E. V. Rozhdestvensky, S. A. Nimirskaya
Published 2018-02-01